Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 SEK | -8.13% |
|
+50.02% | +50.02% |
Jul. 01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
May. 22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- ACTI Stock
- 0GQU Stock
- Revisions Active Biotech AB